Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans (Q47682285)

4 February 2018

title

Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans (English)

1 reference

4 February 2018

0 references

2

Fairbanks LD

1 reference

4 February 2018

Elizabeth Carrey

3

object named as

Carrey EA

1 reference

4 February 2018

Catherine M. Hawrylowicz

4

1 reference

4 February 2018

Anne Simmonds

7

object named as

Simmonds HA

1 reference

4 February 2018

author name string

Rückemann K

1

1 reference

4 February 2018

Richards DF

5

1 reference

4 February 2018

Kirschbaum B

6

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

4 February 2018

Journal of Biological Chemistry

published in

1 reference

4 February 2018

volume

273

1 reference

4 February 2018

issue

34

1 reference

4 February 2018

page(s)

21682-21691

1 reference

4 February 2018

Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection

cites work

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

In vitro and in vivo effects of leflunomide, brequinar, and cyclosporine on pyrimidine biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

Leflunomide interferes with pyrimidine nucleotide biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

The development of Brequinar as an immunosuppressive drug for transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

In vitro and in vivo studies on the combination of Brequinar sodium (DUP-785; NSC 368390) with 5-fluorouracil; effects of uridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

Inhibition of smooth muscle cell proliferation in vitro by leflunomide, a new immunosuppressant, is antagonized by uridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

Abnormal tyrosine phosphorylation on T-cell receptor in lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

Leflunomide, a reversible inhibitor of pyrimidine biosynthesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the compare program

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

Functional expression of a fragment of human dihydroorotate dehydrogenase by means of the baculovirus expression vector system, and kinetic investigation of the purified recombinant enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

Enzymes of nucleotide biosynthesis: differences between intact and lysed cells as well as between species and tissues can be important

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

Proteolytic cleavage of the multienzyme polypeptide CAD to release the mammalian aspartate transcarbamoylase. Biochemical comparison with the homologous Escherichia coli catalytic subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.273.34.21682

21 January 2018

Identifiers

DOI

10.1074/JBC.273.34.21682

1 reference

4 February 2018

1 reference

4 February 2018